Flt3 is a class 111 tyrosine kinase receptor expressed on primitive human and murine hematopoietic progenitor cells (HPC). In previous studies using stroma-free short term assays, Ftt3 ligand (FL) has been shown t o induce proliferation of HPC at proportions similar t o or less than c-kit ligand (steel factor, SF). Using long term stromal cocultivation assays, we studied the effects of FL on proliferation and differentiation of a highly primitive and cytokine nonresponsive subpopulation of human HPC, CD34+CD38-cells. Cell proliferation was significantly greater with FL than with SF, when used individually or in combinations with interleukin-3 (IL-3) andlor IL-6. The effect of FL was greater on bone marrow (BM) CD34+CD38-cells than the more cytokine responsive cord blood CD34+CD38-cells. Little or no effect was seen with FL on more mature CD34+CD38+ cells from either BM or cord blood. The frequency of colony-forming units (CFU) and high proliferative potential-colony forming LT3 IS A RECENTLY discovered member of the class F 111 tyrosine kinase receptor family, which includes ckit and c -~s . ' -~ In murine bone marrow (BM), Flt3 is preferentially expressed on primitive hematopoietic progenitor cells (HPC) and is largely restricted in human hematopoietic cells to the CD34+ progenitor populati~n.',~,~ The expression of Flt3 on human and murine HPC has led to the hypothesis that its ligand may have an important role in proliferation of primitive hematopoietic progenitors.
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In murine bone marrow (BM), Flt3 is preferentially expressed on primitive hematopoietic progenitor cells (HPC) and is largely restricted in human hematopoietic cells to the CD34+ progenitor populati~n.',~,~ The expression of Flt3 on human and murine HPC has led to the hypothesis that its ligand may have an important role in proliferation of primitive hematopoietic progenitors.
Several murine studies have shown that Flt3 ligand (FL) induces proliferation of highly purified HPC in synergism with a number of other growth factors including interleukin-6 (IL-6), IL-11, IL-12, granulocyte colony-stimulating factor (G-CSF), and IL-3.5-7 Studies of the effect of FL on human cells have been more limited. FL had effects on human CD34+ cells similar to those described in murine studies, ie, alone or ill combination with IL-3, granulocyte-macrophage CSF (GM-CSF), Pixy 321, or erythropoietin, FL caused cell proliferation and enhanced colony Muench et a1," studying CD34TD38-h-human fetal liver cells, found that FL acted in synergism with GM-CSF to induce expansion of high proliferative potential colony-forming cells (HPP-CFC), a highly primitive progenitor population. Each of these reports used short-term (<21 days) liquid suspension or semisolid cultures to examine the effect of FL to induce proliferation of murine or human HPC. In all comparisons with FL with another early acting cytokine steel factor (SF), FL was either similar or inferior to SF either as a single agent or in combination with other cytokines.
We report that a far more impressive proliferative response specific to FL is obtained when a primitive human HPC population, CD34+CD38-cells, is studied during longterm culture on stromal support. Previous work has shown that CD34TD38-BM cells are a primitive and highly quiescent population of cells with low cloning efficiency, even when stimulated with a combination of the early acting cytokines IL-3, IL-6, and SF."." CD34TD38-cells are distinguished from the more mature and numerous CD34TD38' cells (HPP-CFC) during early culture (130 days) was increased by both SF and FL t o similar levels. However, in the LTC-IC period (35 t o 60 days) and extended long-term culture initiating cell (ELTC-IC) period (>60 days), the frequency of CFU and HPP-CFC was significantly greater in cultures containing FL than those without FL ( P < .0025). Fluorescenceactivated cell sorter analysis of cultures after 21 days showed a significantly higher percentage of cells remained CD34+ in the combination of FL, IL-3, IL-6, and SF (F/3/6/S) than in 3161s (0.7846 ? 0.5290 ~0.21% ? 0.2990 respectively, mean 2 SD). Cloning efficiency o f BM CD34+CD38-cells was significantly increased by the addition of FL t o the combination of 31615 (mean 11.7% vO.5%, P e .0001). These data show that FL is able t o induce proliferation of CD34+CD38-cells that are nonresponsive t o other early acting cytokines and t o improve the maintainence of progenitors in vitro. 0 1996 b y The American Society of Hematology.
progenitors by their sustained clonogenicity in stromal cocultivation cultures." This sustained clonogenicity demonstrates enrichment of progenitor output from long-term culture-initiating cells (LTC-IC) and extended long-term culture-initiating cells (ELTC-IC). In this report, we have found that FL is highly synergistic with IL-3, IL-6, and SF in inducing proliferation of CD34'CD38-BM cells and results in expansion of colony-forming units (CFU) from LTC-IC and ELTC-IC. In these long-term assays, the effects of FL are significantly greater than with SF and are achieved at least in part by increasing the proportion of quiescent cells capable of responding to cytokine stimulation. In addition, FL's effects on progenitor output in extended long-term culture may be also caused by an enhancement in the maintenance of progenitors in vitro. CD34'CDW cells were defined strictly as those cells in RI with high CD34 antigen expression and anti-CD38 PE fluorescence less than half of the maximum PE fluorescence of the isotype control.
In Fig LnrlR-terrn srrorncrl crtltrtres and rnethylcellrrlose cultrrres. BM stroma was produced by culturing fresh BM mononuclear cells for at least 2 weeks in stromal medium (12.5% horse serum. . penicillidstreptomycin and glutamine). Macrophages were depleted from the stromal cultures by trypsinizing and replating at least three times before final use in the long-term cultures. One or two days before cell sorting, allogeneic BM stroma was irradiated with 20 Gy and plated (7 X IO7 cells/well) in 96-well plates (Falcon: BD Labware. Lincoln Park. NJ) to form preestablished stromal layers for the long-term cultures. Two hundred to five hundred cells with either the CD34-CD.78-or a CD34-CD38-immunophenotype were sorted into each individual well of the 96-well plates and cultured on the irradiated stroma in "basal medium" containing IMDM, 308 FCS. 10% bovine serum albumin (BSA; Sigma), 2-mercaptoethanol, 1O-6 molL hydrocortisone, penicillinlstreptomycin. glutamine. and various combinations of the growth factors: IL-3, 10 ng/mL: IL-6. 50 U h L ; SF. 50 nglmL: and FL 50 U/mL.
12.5%
To measure progenitor content, adherent and nonadherent cells were removed every 2 to 3 weeks, counted. and aliquots were replated into semisolid media (1.3% methylcellulose with IL-3, I O ng/ mL; IL-6, 50 UlmL; SF, 50 ng/mL; GM-CSF. 50 ng/mL: and 2 U/ mL erythropoietin. CFU-C and HPP-CFC were counted after 2 to 3
For personal use only. on March 30, 2017. by guest www.bloodjournal.org From To analyze CD34' cell content of cultures after stimulation in different growth factors, adherent and nonadherent cells were removed after 21 to 30 days, counted, washed, and incubated with 20 pL of human intravenous Ig (IVIg) (10 mg/mL) for IO minutes to block nonspecific binding to Fc receptors. The cells were then stained with FITC-labeled anti-CD34 for 20 minutes. Cells from the same cultures were also stained with isotype controls as described above. Approximately 30,000 events were acquired in list mode data file and analyzed by Cellquest software. CD34' cells were defined as those in the lymphoid gate with FITC expression greater than the isotype control. Cells showing a nonspecific pattern of staining were excluded from the estimation of CD34' cell frequency.
To determine whether FL increases the cloning efficiency of CD34'CD38-cells, BM CD34'CD38-cells were sorted as single cells into 96-well plates, using the ACDU (Automated Cell Deposition Unit) on the FACSVantage. The culture plates were prepared I to 2 days before cell sorting with preestablished irradiated BM stromal layers and basal FACS analysis of cultured cells.
Cloning efficiency of CD34'CD3R-cells. medium with either ( I ) no growth factors, (2) FL alone. (3) 3/6/S. or (4) F/3/6/S. Cultures were fed once a week by replacing half the supernatant with fresh medium. Plates were observed every week and wells with greater than 100 cells were considered positive. The percent cloning efficiency was defined as the number of positive wells divided by the total number of wells plated multiplied by 100.
RESULTS
Effects of FL on skort-term proliferation from CD34-CD38-cells. Our previous studies have shown that the combination of IL-3, IL-6, and S F (3161s) induces cell proliferation from CD34TD38-BM and cord blood cells when cocultivated on BM stroma." Our initial investigations into the effects of FL determined whether the addition of FL to the previously used combination of 3161s would enhance short-term proliferation of CD34'CD38-cells. BM CD34TD38-cells were FACS sorted and cultured in either 3161s or F/3/6/S, with or without stroma. In both the absence and presence of stroma, the addition of FL to 3/6/S significantly increased cell proliferation from BM CD34'CD38-cells (Table I ). In the absence of stroma, cell proliferation from CD34TD38-BM cells grown in 3161s was not measurable. In contrast, when FL was added to the 3/6/S combination, cell number increased from day 0 to day 2 1 by 4-to 400-fold (n = 3). The presence of stroma significantly increased cell numbers in both 3161s and F/3/6/S, but the latter combination still induced a higher proliferation than did 3/6/S.
Significant differences in cell cycling, cytokine responsiveness, and progenitor content have been previously noted between CD34'CD38' cells and CD34TD38-cells in cord blood and BM." We next compared the cytokine responsiveness of FL on these four functionally distinct progenitor subpopulations (Fig 2) . The most marked effect of FL was seen on the most quiescent subpopulation of cells, the CD34TD38-cells in BM, with a mean 15.6-fold greater increase in cell expansion at day 21 in F/3/6/S than in 3/61 S (Table I ) 
The effect of FL on cord blood CD34'CD38-cells was less dramatic, with only a twofold greater expansion in F/3/ 6/S than in 3161s (Fig 2) . The smaller fold increase may have been due in part to the marked proliferation of cord blood cells in 3161s without the presence of FL. The effect of FL on the more committed and cycling CD34'CD38' 
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For personal use only. on March 30, 2017. by guest www.bloodjournal.org From cells in cord blood and BM was significantly less than on CD34TD38-cells from either source with no synergism and less than additive enhancement when FL was added to 3161s. Thus, the synergism of FL with 3161s was restricted to highly quiescent CD34TD38-cells of BM, a population that is known to be relatively nonresponsive to other growth factors in terms of delayed onset of proliferation and low cloning efficiency." Similar short-term proliferation studies were used to determine which of the individual cytokines in the 3/66 combination are synergistic with FL in inducing early proliferation of BM CD34TD38-cells. FL was more effective as a single agent than either IL-3, IL-6, or SF individually (Fig 3) cells without stroma for more than 21 days led to rapid cell differentiation and a decrease in cell numbers in both 3161s and F/3/6/S. To study the effect of FL in longer-term assays, we chose to use stromal cocultivation for the longer culture periods.
CD34TD38-cells were cocultured with stroma in various growth factor combinations for over 100 days. Total adherent and nonadherent cells from each culture were counted every 2 to 3 weeks. In combinations that contained FL, cell expansion was greater at all time points and continued for longer than in the corresponding combinations without FL. Figure 4 shows the fold increase over time of cells generated from BM CD34TD38-cells cultured on stroma in various growth factor combinations in one representative experiment of a total four experiments. In the cultures that contained FL, there was an early peak of growth between days 45 and 60 and a second smaller peak that appeared around days 85 through 95. In contrast, cultures that did not contain FL did not have the second peak of proliferation. Although there is sample to sample variation as to the exact To measure the progenitor content of the cell expansion occurring in each growth factor combination, adherent and nonadherent cells were pooled and aliquots plated in methylcellulose every 2 to 3 weeks throughout the duration of stromal cocultivation. Figure 5 shows the frequency of CFU and HPP-CFC from the stromal cultures at days 30 and 56 in one representative experiment. At day 30, CD34TD38-cells grown in all of the growth'factor combinations were able to produce CFU. FL increased the frequency of CFU when added to either IL-3 or IL-6 to the same extent as did SF. However, HPP-CFC were seen at a higher frequency in combinations containing FL. In contrast, at day 56 all cultures containing FL produced a significantly higher frequency of HPP-CFC and CFU than the corresponding growth factor combinations without FL ( P < .0025, using square root transformation of the data). The addition of FL to 3161s increased the frequency of CFU 20-fold at day 56. At day 72, only combinations that contained FL were able to produce either CFU or HPP-CFC (data not shown). BM CD34TD38-cells were sorted onto irradiated BM stroma in either 3161s or F/3/6/S and analyzed by FACS for the presence of CD34' cells after 21 to 30 days of culture ( Table  2 ). In the presence of 3/6/S, 0.21 t 0.29% (mean -t SD, n = 3) of the cultured cells retained CD34 antigen expression. In contrast, 0.78% t 0.52% of the cells in cultures with Fl 3161.5 were CD34' after 21 to 30 days in culture. Taking into account the greater overall cell expansion in Fl3/6/S, the total number of CD34' cells in F/3/6/S was 20 to 126 greater than in 3161s.
FL increases cloning efJiciency of BM CD34'CD38-cells. We next determined whether the marked proliferation of CD34TD38-cells seen with FL is caused by recruitment of normally cytokine nonresponsive cells to enter cell cycle and proliferate. BM CD34TD38-cells were sorted as single cells into 96-well plates onto preestablished stromal layers
CD34' cell content of cultures is maintained by FL.
For
Day of Longterm Culture
with either no growth factors, FL, 3/6/S, or F/3/6/S. Cloning efficiency was defined as the number of positive wells (wells which contained at least 50 cells) divided by the total number of wells plated. Wells were scored every 7 days to determine the time of onset of clonal proliferation of each individual CD34TD38-cell (Fig 6) . The addition of FL to 3161s significantly increased cloning efficiency from a mean of 0.5% with 3161s to 11.7% with F/3/6/S (P < .OOOl, using a Student's r-test). We have previously shown in similar cloning efficiency studies, that a subpopulation of CD34TD38-cells from cord blood begin to proliferate as late as 80 days of culture with 3I6lS.I' In the current studies with BM, a very low cloning efficiency from CD34TD38-cells grown in 3161s was seen with most clones appearing by day 35. Day 35 cloning efficiency was significantly higher in F/3/6/S (4.7% u 0.26% in 3/6/S, P < .Owl). The addition of FL also increased the percentage of CD34TD38-cells proliferating late in culture (7.0% of cells in F/3/6/S u 0.24% in 3161s first formed clones after day 35 (P < .OOOl). An analysis of covariance of the data at all time points showed that F1 3/66 significantly increased the cloning efficiency of 3161s over the entire 84-day period of culture (P = 0, power = 1, using a Tukey's pairwise comparison procedure). Thus, the addition of FL to 3161s significantly increased the frequency of CD34TD38-cells able to proliferate at both early and late time points. FL alone also resulted in a higher cloning efficiency of CD34TD38-cells than did the 3161s combination with its predominant effect late in culture.
DISCUSSION
These studies show that FL is able to induce profound cell proliferation from the primitive and relatively cytokine nonresponsive CD34'CD38-progenitor population in BM. Single-cell plating shows that the cell output induced by FL is due at least in part to its ability to increase the percentage of BM CD34'CD38-cells able to respond to the cytokines IL-3, IL-6 and SF. Evidence that FL has unique effects on the most functionally primitive progenitors is provided by its dominant effect on progenitor output late in culture.
In this report, both the synergism of FL with other growth factors and its action as a single agent were significantly more impressive than in previous studies of both human and
The proliferative effects of FL do not appear to overlap entirely with SF as previously suggested.7.9. IO. 13 In our studies, the effects of FL were most profound in the most quiescent subpopulation, the BM CD34TD38-cells, and were minimal in the more mature and cytokine responsive CD34TD38' cells. Cord blood CD34TD38-cells are more responsive to IL-3, IL-6, and SF than are BM CD34'CD38-cells with a more rapid onset of proliferation and higher cloning efficiency." The effect of FL on cord blood CD34TD38-cells was accordingly less impressive than on CD34'CD38-cells in BM. The use of human progenitor populations which are less quiescent murine ~pc.6.7.IO.l3
For personal use only. on March 30, 2017. by guest www.bloodjournal.org From and respond more readily to cytokine stimulation will not show the unique effect of FL on quiescent cells demonstrated in this r e p~r t . '~. '~. '~ Previous studies of FL have measured proliferation and progenitor output in relatively short-term a s~a y s . 6~~~~~~~'~~'~ Th e effects of FL on progenitor output in short-term culture of cytokine responsive cells are similar to those of SF, revealing a degree of redundancy between the two cytokines. In our own studies the unique effect of FL on progenitor output was not apparent until the end of the standard LTC-IC period (day 56) and was most impressive in the ELTC-IC period (day 72). Thus, FL acts on a subpopulation of CD34+CD38-cells that produce progenitors late in culture, likely representing a more primitive subpopulation of HPC.
Two other studies have used stromal long-term cultures to show the ability of FL to induce proliferation of primitive progenitors. Small et a14 found that antisense oligonucleotides against STK-1 (the human homolog of murine Flt3) inhibited production of CFU most strongly in "long term" (3 to 4 week) stromal cocultures. Gabbianelli et all4 recently reported that FL increased progenitor output in 5 to 7-week stromal cocultures, suggesting a proliferative effect on LTC-IC. The use of stromal cocultivation, although necessary to measure long-term progenitor output, makes it unclear whether the effects observed on primitive HPC can be attributed solely to FL or are the result of an interaction of FL with either soluble and/or adherent factors produced from stroma. However, at least equivalent levels of synergism were seen with FL and IL-3, IL-6, and SF in the absence of stroma. Thus, stroma is not required for early proliferation of CD34TD38-cells in response to FL.
Zeigler et a13 reported that Flt3 expression on murine HPC is present only in the subpopulation of AA4+Sca+lid0CD34+ cells that are in cell cycle and is absent on those in GO phase. In contrast, expression of c-kit is present on both cycling and noncycling murine HPC. The relationship of Flt3 expression and cell cycle status of human CD34TD38-cells has not yet been reported and may not be identical to murine hematopoietic stem cells. It is possible that the interaction of HPC with stroma by the production of soluble or adhesion factor(s) may induce expression of Flt3 and consequently allow proliferation of HPC in response to FL.
The finding that FL increases not only early but also late clonal proliferation suggests a more complex role for this cytokine than simply induction of proliferation of normally quiescent HPC. It seems unlikely that cells which begin to proliferate only after 80 days of continuous exposure to FL do so as a direct and exclusive effect of FL. It is possible that the persistence of CD34+ cells in culture and the increase in late clonal proliferation reflect an ability of FL to maintain primitive HPC in culture.
The effects of FL on proliferation and possibly also on the maintenance of highly primitive HPC in vitro may have important implications for the field of gene therapy. Hematopoietic progenitors that do not respond to stimulation by other known cytokines are believed to represent the most primitive subpopulation of HPC, and are likely to include the long-term reconstituting cells. l5 Gene transfer levels into human hematopoietic stem cells using retroviral vectors have been disappointingly low in all clinical trials reported thus far, presumably because of the inability to induce cell cycling of true stem cells during a short transduction p e r i~d . '~-'~ Prolonged cytokine stimulation in vitro leads inexorably to the loss of both mature and primitive HPC. The studies reported here show that FL is able to induce proliferation of primitive and normally cytokine resistant hematopoietic progenitors and may enhance maintenance of HPC in vitro, suggesting that stimulation with FL may provide a significant improvement in gene transfer into human hematopoietic stem cells.
